{"url_path":"/sec/atos/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1488039/0001193125-26-213423-index.html","accession_number":"0001193125-26-213423","cik":"0001488039","ticker":"ATOS","issuer_name":"ATOSSA THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1488039/0001193125-26-213423-index.html","primary_entity_key":"0001488039","primary_entity_name":"ATOSSA THERAPEUTICS, INC."},"word_count":300,"has_tables":true,"body_markdown":"ITEM 6. EXHIBITS\n\nEXHIBIT INDEX\n\nIncorporated by Reference Herein or Filed or Furnished Herewith\n\nExhibit\n\nNo.\n\nDescription\n\nForm\n\nDate\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n10.1\n\n \n\n[At the Market Offering Agreement, dated February 20, 2026, by and between Atossa Therapeutics, Inc. and Rodman & Renshaw LLC.](https://www.sec.gov/Archives/edgar/data/1488039/000119312526061412/d100198dex11.htm)\n\n \n\nCurrent Report on Form 8-K, as Exhibit 1.1\n\n \n\nFebruary 20,2026\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n10.2\n\n \n\n[Form of Restricted Stock Award Agreement under the 2020 Stock Incentive Plan](atos-ex10_2.htm)\n\n \n\nFiled herewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n31.1\n\n \n\n[Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act](atos-ex31_1.htm)\n\n \n\nFiled herewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n31.2\n\n \n\n[Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act](atos-ex31_2.htm)\n\n \n\nFiled herewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n32.1(1)\n\n \n\n[Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act](atos-ex32_1.htm)\n\n \n\nFurnished herewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n32.2(1)\n\n \n\n[Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act](atos-ex32_2.htm)\n\n \n\nFurnished herewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n101.INS\n\n \n\nInline XBRL Instance Document\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema Document With Embedded Linkbase Documents\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)\n\n \n\n \n\n \n\n \n\n \n\n(1) The certification that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.\n\n \n\n48\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nDate: May 8, 2026\n\n \n\n/s/Steven C. Quay\n\n \n\nChairman, President and Chief Executive Officer (On behalf of the registrant)\n\n \n\n \n\n \n\n \n\n \n\n/s/Mark J. Daniel\n\n \n\nChief Financial Officer (as Principal Financial and Accounting Officer)\n\n \n\n \n\n \n\n49"}